Oncolytics Biotech:Reo 33试验A部分肿瘤反应初步更新预计2026年底前公布;B部分招募或于2027年一季度启动

美股速递
Jul 13

Oncolytics Biotech Inc宣布,其Reo 33临床试验的A部分初步肿瘤反应数据更新,预计将在2026年年底前获得。与此同时,该试验的B部分患者招募工作,有望于2027年第一季度正式启动。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10